SYNH [NASD]
Syneos Health, Inc.
Index- P/E30.93 EPS (ttm)2.31 Insider Own0.40% Shs Outstand103.67M Perf Week2.16%
Market Cap7.21B Forward P/E12.41 EPS next Y5.76 Insider Trans-1.76% Shs Float61.25M Perf Month-7.37%
Income242.30M PEG2.28 EPS next Q1.20 Inst Own98.90% Short Float3.34% Perf Quarter-9.07%
Sales5.34B P/S1.35 EPS this Y22.30% Inst Trans-1.38% Short Ratio2.65 Perf Half Y-29.79%
Book/sh31.85 P/B2.24 EPS next Y12.11% ROA3.00% Target Price95.33 Perf Year-19.43%
Cash/sh1.18 P/C60.52 EPS next 5Y13.55% ROE7.30% 52W Range66.73 - 104.18 Perf YTD-30.40%
Dividend- P/FCF22.20 EPS past 5Y2.00% ROI4.90% 52W High-31.40% Beta1.77
Dividend %- Quick Ratio1.10 Sales past 5Y26.50% Gross Margin23.30% 52W Low7.10% ATR3.11
Employees26751 Current Ratio1.10 Sales Q/Q10.60% Oper. Margin7.50% RSI (14)47.01 Volatility3.96% 4.64%
OptionableYes Debt/Eq0.90 EPS Q/Q20.40% Profit Margin4.50% Rel Volume0.51 Prev Close70.91
ShortableYes LT Debt/Eq0.89 EarningsApr 29 BMO Payout0.00% Avg Volume774.00K Price71.47
Recom2.20 SMA200.85% SMA50-6.65% SMA200-18.75% Volume398,149 Change0.79%
Apr-25-22Downgrade Jefferies Buy → Hold $101 → $75
Apr-12-22Initiated Deutsche Bank Buy $102
Dec-15-21Downgrade Citigroup Buy → Neutral $115 → $105
Aug-05-21Resumed Credit Suisse Outperform $96
Mar-03-21Initiated Barclays Equal Weight $84
Oct-06-20Upgrade Mizuho Neutral → Buy $65
Oct-01-20Upgrade Goldman Neutral → Buy $69 → $75
Mar-30-20Downgrade Goldman Buy → Neutral $79 → $45
Jan-07-20Initiated Citigroup Buy $75
Oct-19-18Upgrade William Blair Mkt Perform → Outperform
Oct-09-18Initiated UBS Buy
Oct-04-18Initiated Evercore ISI Outperform $58
May-10-22 09:00AM  
May-02-22 08:31AM  
Apr-29-22 01:05PM  
07:45AM  
06:26AM  
06:24AM  
Apr-22-22 03:00PM  
Apr-19-22 08:00AM  
Apr-14-22 10:06AM  
Apr-11-22 04:05PM  
Mar-29-22 06:44AM  
Mar-28-22 09:35AM  
Mar-23-22 08:47AM  
Mar-18-22 09:40AM  
Mar-10-22 09:13AM  
Mar-07-22 08:00AM  
Feb-28-22 08:51AM  
Feb-18-22 09:19AM  
Feb-17-22 07:35AM  
06:10AM  
Feb-10-22 03:01PM  
Feb-07-22 05:38PM  
01:57PM  
Feb-04-22 07:52AM  
Feb-01-22 07:26AM  
Jan-27-22 01:27PM  
Jan-21-22 01:38PM  
Jan-18-22 05:38PM  
06:16AM  
Jan-11-22 01:38PM  
09:00AM  
Jan-04-22 09:06AM  
Dec-28-21 10:42AM  
Dec-23-21 08:28AM  
Dec-21-21 09:00AM  
02:38AM  
Dec-18-21 08:38PM  
Dec-13-21 09:02AM  
Dec-09-21 12:41PM  
Dec-07-21 11:38AM  
Dec-03-21 11:31AM  
Nov-23-21 07:52AM  
Nov-19-21 10:20AM  
Nov-16-21 10:00AM  
Nov-12-21 10:49AM  
09:27AM  
Nov-11-21 09:00AM  
03:00AM  
Nov-04-21 09:04AM  
Nov-03-21 01:00PM  
07:35AM  
06:16AM  
Oct-27-21 03:03PM  
Oct-20-21 09:53AM  
Oct-19-21 09:32AM  
Oct-18-21 12:53PM  
Oct-13-21 09:30AM  
Oct-08-21 08:44AM  
Oct-06-21 08:16AM  
Sep-29-21 10:41AM  
Sep-20-21 12:33PM  
08:31AM  
Sep-16-21 09:40AM  
Sep-14-21 05:30PM  
Sep-10-21 10:00AM  
Sep-09-21 09:00AM  
07:00AM  
Sep-08-21 11:30AM  
Aug-31-21 09:22AM  
Aug-30-21 09:00AM  
Aug-20-21 01:47PM  
Aug-10-21 09:56AM  
Aug-09-21 05:30PM  
07:35AM  
06:12AM  
Aug-02-21 03:01PM  
07:00AM  
Jul-21-21 06:35AM  
Jul-14-21 08:00AM  
Jul-12-21 04:05PM  
03:39PM  
Jun-21-21 09:23AM  
08:05AM  
Jun-08-21 07:40AM  
Jun-03-21 10:00AM  
05:19AM  
Jun-02-21 04:01PM  
May-21-21 01:51PM  
05:56AM  
May-14-21 08:13PM  
May-06-21 07:30AM  
May-03-21 09:33PM  
04:40PM  
07:00AM  
May-01-21 10:30AM  
Apr-30-21 09:01AM  
05:05AM  
Apr-29-21 07:35AM  
06:16AM  
Apr-22-21 12:33PM  
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kralowetz Donna HildebrandSVP, Chief Accounting OfficerJan 31Sale90.001,05594,9506,685Feb 02 05:12 PM
Brooks Michael LeeSee remarksDec 30Sale103.00939,5798,738Jan 03 05:09 PM
Olefson JonathanGeneral Counsel & Corp SectyDec 23Sale100.951,889190,69520,775Dec 27 05:03 PM
Brooks Michael LeeSee remarksDec 22Sale99.00939,2078,831Dec 23 05:02 PM
Harty Linda SDirectorDec 20Sale97.024,122399,9165,167Dec 21 05:06 PM
Kralowetz Donna HildebrandSVP, Chief Accounting OfficerSep 03Sale94.3024823,3866,467Sep 08 05:18 PM
Meggs Jason M.Chief Financial OfficerSep 03Sale95.009,223876,18551,478Sep 03 05:37 PM
Macdonald AlistairChief Executive OfficerAug 03Option Exercise42.7635,5531,520,246231,313Aug 04 05:24 PM
Macdonald AlistairChief Executive OfficerAug 03Sale87.9635,5533,127,268195,760Aug 04 05:24 PM
Macdonald AlistairChief Executive OfficerAug 02Sale89.904,710423,429195,760Aug 04 05:24 PM
Monaghan Matthew E.DirectorJul 16Sale88.6417015,06917,138Jul 19 05:16 PM
Meggs Jason M.Chief Financial OfficerJul 06Option Exercise45.8366030,24661,321Jul 07 05:08 PM
Meggs Jason M.Chief Financial OfficerJul 06Sale90.0066059,40060,701Jul 07 05:08 PM
Meggs Jason M.Chief Financial OfficerJun 30Option Exercise43.004,668200,74363,301Jul 02 05:04 PM
Meggs Jason M.Chief Financial OfficerJun 30Sale90.004,668420,12060,701Jul 02 05:04 PM
Kralowetz Donna HildebrandSVP, Chief Accounting OfficerJun 18Sale85.0359050,1686,467Jun 21 05:03 PM
Maldonado John L.DirectorJun 07Sale81.206,307,489512,168,1070Jun 09 05:55 PM
Allen TomDirectorJun 07Sale81.206,307,489512,168,1070Jun 09 05:51 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerJun 07Sale81.206,307,489512,168,1070Jun 09 05:40 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerJun 07Sale81.206,307,489512,168,1070Jun 09 05:41 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerJun 07Sale81.206,307,489512,168,1070Jun 09 05:40 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerJun 07Sale81.206,307,489512,168,1070Jun 09 05:38 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerJun 07Sale81.206,307,489512,168,1070Jun 09 05:39 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerJun 07Sale81.206,307,489512,168,1070Jun 09 05:38 PM
THOMAS H. LEE ADVISORS, LLCDirectorJun 07Sale81.205,043,008409,492,2500Jun 09 05:25 PM
THOMAS H. LEE ADVISORS, LLCDirectorJun 07Sale81.201,17995,7350Jun 09 05:25 PM
THOMAS H. LEE ADVISORS, LLCDirectorJun 07Sale81.205,043,008409,492,2500Jun 09 05:17 PM
THOMAS H. LEE ADVISORS, LLCDirectorJun 07Sale81.201,17995,7350Jun 09 05:17 PM
Macdonald AlistairChief Executive OfficerJun 01Option Exercise42.884,889209,640205,359Jun 03 05:08 PM
Macdonald AlistairChief Executive OfficerJun 01Sale88.204,889431,210200,470Jun 03 05:08 PM